Price Momentum and Recent Market Performance
The stock closed at ₹570.45 on 2 Feb 2026, marking a 3.10% increase from the previous close of ₹553.30. Intraday, it traded between ₹538.15 and ₹574.75, reflecting heightened volatility. Over the past week, Aster DM Healthcare outperformed the Sensex, delivering a 2.72% return against the benchmark’s 1.00% decline. However, the one-month and year-to-date returns remain negative at -6.67% and -7.43% respectively, underperforming the Sensex’s -4.67% and -5.28% returns over the same periods.
Longer-term performance remains robust, with a 17.55% gain over the past year and an impressive 170.87% return over three years, significantly outpacing the Sensex’s 5.16% and 35.67% respectively. The five-year return of 260.82% further underscores the company’s strong growth trajectory within the hospital sector.
Technical Indicators: Mixed Signals Across Timeframes
The technical landscape for Aster DM Healthcare is characterised by a divergence of signals across weekly and monthly charts. The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly timeframe, signalling potential short-term selling pressure. Conversely, the monthly MACD is mildly bearish, suggesting a less pronounced downtrend over the longer term.
The Relative Strength Index (RSI) offers no definitive signals on either weekly or monthly charts, indicating a neutral momentum without clear overbought or oversold conditions. This lack of directional RSI signal implies that the stock is consolidating, awaiting a catalyst for a decisive move.
Bollinger Bands present a contrasting picture: mildly bearish on the weekly chart but bullish on the monthly chart. This suggests that while short-term price volatility may be contracting with a slight downward bias, the longer-term trend retains upward momentum.
Moving Averages and Trend Analysis
Daily moving averages have shifted to a mildly bullish stance, reflecting recent price gains and signalling potential support for further upside. This is a positive development for traders looking for confirmation of a trend reversal from the previous sideways movement.
However, the Know Sure Thing (KST) oscillator remains bearish on the weekly timeframe, indicating caution in the short term, while it is bullish on the monthly timeframe, reinforcing the longer-term positive outlook. The Dow Theory assessment aligns with this mixed view, mildly bearish weekly but no clear trend monthly, highlighting the stock’s current phase of transition.
Volume and On-Balance Volume (OBV) Insights
On-Balance Volume (OBV) shows no clear trend on either weekly or monthly charts, suggesting that volume is not currently confirming the price moves. This absence of volume confirmation may imply that the recent price gains lack strong institutional support, warranting careful monitoring by investors.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
Mojo Score and Analyst Ratings
Aster DM Healthcare’s current Mojo Score stands at 34.0, categorised as a Sell rating, a downgrade from the previous Hold grade as of 27 Jan 2026. This downgrade reflects a reassessment of the company’s risk-reward profile amid the mixed technical signals and recent price volatility. The Market Cap Grade is 3, indicating a mid-tier market capitalisation relative to peers in the hospital sector.
The downgrade to Sell suggests that analysts and algorithmic models are cautious about the stock’s near-term prospects despite its longer-term growth potential. Investors should weigh this against the stock’s historical outperformance over multi-year horizons.
Valuation Context and Price Range
The stock’s 52-week high of ₹732.00 and low of ₹386.15 provide a wide trading range, with the current price of ₹570.45 sitting closer to the mid-point. This positioning indicates that while the stock has retraced from its highs, it remains well above its lows, signalling resilience in the face of sector headwinds.
Comparing the stock’s returns to the Sensex over various periods highlights its relative strength, particularly over the medium to long term. However, the recent underperformance on a one-month and year-to-date basis suggests short-term pressures that may be technical or fundamental in nature.
Implications for Investors
The shift from a sideways to a mildly bullish technical trend, supported by daily moving averages and monthly bullish KST and Bollinger Bands, offers a cautiously optimistic outlook. However, the bearish weekly MACD, KST, and Dow Theory signals, combined with neutral RSI and lack of volume confirmation, counsel prudence.
Investors should monitor key support levels near ₹538 and resistance around ₹575 to gauge the sustainability of the current momentum. A decisive break above the recent high could validate the bullish shift, while a failure to hold support may signal a return to consolidation or decline.
Holding Aster DM Healthcare Ltd from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Sector and Industry Context
Within the hospital sector, Aster DM Healthcare operates in a competitive environment where operational efficiency, regulatory compliance, and patient volume growth are critical. The stock’s technical signals may reflect broader sector dynamics, including fluctuating healthcare demand and cost pressures.
Investors should consider these external factors alongside technical analysis to form a comprehensive view. The company’s long-term outperformance relative to the Sensex suggests strong fundamentals, but the recent technical caution flags the need for vigilance in the near term.
Conclusion
Aster DM Healthcare Ltd’s recent technical parameter changes reveal a stock in transition. While daily moving averages and monthly indicators hint at emerging bullish momentum, weekly bearish signals and neutral volume trends temper enthusiasm. The downgrade in Mojo Grade to Sell further emphasises the need for careful analysis before committing fresh capital.
For investors with a medium to long-term horizon, the stock’s historical returns and sector positioning remain attractive. However, short-term traders should watch for confirmation of trend direction through price action and volume before making decisive moves.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
